1. Home
  2. NRXP vs AWRE Comparison

NRXP vs AWRE Comparison

Compare NRXP & AWRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • AWRE
  • Stock Information
  • Founded
  • NRXP 2015
  • AWRE 1986
  • Country
  • NRXP United States
  • AWRE United States
  • Employees
  • NRXP N/A
  • AWRE N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • AWRE Computer Software: Prepackaged Software
  • Sector
  • NRXP Health Care
  • AWRE Technology
  • Exchange
  • NRXP Nasdaq
  • AWRE Nasdaq
  • Market Cap
  • NRXP 34.7M
  • AWRE 31.6M
  • IPO Year
  • NRXP N/A
  • AWRE 1996
  • Fundamental
  • Price
  • NRXP $1.98
  • AWRE $1.64
  • Analyst Decision
  • NRXP Strong Buy
  • AWRE
  • Analyst Count
  • NRXP 4
  • AWRE 0
  • Target Price
  • NRXP $28.25
  • AWRE N/A
  • AVG Volume (30 Days)
  • NRXP 128.2K
  • AWRE 23.0K
  • Earning Date
  • NRXP 05-13-2025
  • AWRE 04-30-2025
  • Dividend Yield
  • NRXP N/A
  • AWRE N/A
  • EPS Growth
  • NRXP N/A
  • AWRE N/A
  • EPS
  • NRXP N/A
  • AWRE N/A
  • Revenue
  • NRXP N/A
  • AWRE $17,389,000.00
  • Revenue This Year
  • NRXP N/A
  • AWRE N/A
  • Revenue Next Year
  • NRXP N/A
  • AWRE N/A
  • P/E Ratio
  • NRXP N/A
  • AWRE N/A
  • Revenue Growth
  • NRXP N/A
  • AWRE N/A
  • 52 Week Low
  • NRXP $1.10
  • AWRE $1.35
  • 52 Week High
  • NRXP $6.01
  • AWRE $2.97
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 48.76
  • AWRE 58.46
  • Support Level
  • NRXP $1.85
  • AWRE $1.44
  • Resistance Level
  • NRXP $1.97
  • AWRE $1.56
  • Average True Range (ATR)
  • NRXP 0.16
  • AWRE 0.09
  • MACD
  • NRXP 0.03
  • AWRE 0.01
  • Stochastic Oscillator
  • NRXP 71.43
  • AWRE 93.10

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

Share on Social Networks: